Merck - 49 Year Stock Price History | MRK

Historical daily share price chart and data for Merck since 1970 adjusted for splits. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Merck as of March 19, 2019 is 81.91.
Merck Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 77.7481 75.5900 81.9100 72.9200 81.9100 7.20%
2018 63.1434 54.5318 78.7735 52.0874 76.4100 40.00%
2017 59.3035 56.6015 63.6280 52.0295 54.5803 -1.47%
2016 53.1907 47.8398 60.6662 44.2938 55.3970 15.05%
2015 50.6158 50.4424 55.5934 43.7529 48.1498 -3.87%
2014 49.6228 42.3514 54.1683 42.3514 50.0896 16.95%
2013 38.9197 34.1074 42.8306 33.7032 42.8306 26.80%
2012 33.3142 30.3333 39.1858 29.5493 33.7774 13.13%
2011 26.3398 27.2581 30.0165 23.0533 29.8581 9.54%
2010 26.6144 26.8405 29.7558 23.3143 27.2581 2.86%
2009 20.9224 21.3231 27.5584 14.6746 26.4996 26.73%
2008 24.8076 37.7698 39.8634 15.9761 20.9104 -45.34%
2007 32.8590 28.1208 40.0082 27.4308 38.2570 37.36%
2006 23.9906 20.1012 29.2708 20.1012 27.8525 42.66%
2005 18.3016 18.2527 20.6408 15.6636 19.5242 4.04%
2004 23.9595 26.4576 27.6255 14.9761 18.7665 -27.76%
2003 28.4178 30.1548 33.1740 22.6386 25.9796 -11.35%
2002 27.5785 30.1630 32.6713 19.9463 29.3058 -1.26%
2001 35.4275 45.9100 45.9100 28.8558 29.6785 -35.79%
2000 36.0945 32.8142 46.7739 26.2983 46.2210 41.78%
1999 35.2340 35.7839 41.4106 29.3328 32.6007 -7.48%
1998 30.5214 25.3085 37.9100 24.2030 35.2345 41.32%
1997 22.0029 18.4458 25.2379 18.4458 24.9322 35.61%
1996 15.5329 14.5246 19.3572 12.9497 18.3857 23.92%
1995 11.0495 8.4578 15.1192 8.0435 14.8366 76.57%
1994 7.2031 7.5035 8.6782 6.0940 8.4028 14.82%
1993 7.3500 9.0662 9.0662 6.0185 7.3183 -18.35%
1992 9.9220 11.2363 11.4045 8.4517 8.9629 -20.29%
1991 8.0212 5.9280 11.2444 5.4478 11.2444 88.88%
1990 5.1646 5.0778 5.9532 4.3627 5.9532 18.95%
1989 4.4953 3.6092 5.1368 3.6092 5.0049 37.47%
1988 3.4044 3.3695 3.7263 2.9827 3.6407 12.05%
1987 3.4462 2.5829 4.4586 2.5829 3.2492 27.96%
1986 1.9599 1.4145 2.6547 1.3876 2.5393 80.84%
1985 1.1255 0.9546 1.4042 0.9264 1.4042 45.74%
1984 0.9083 0.9264 0.9942 0.8174 0.9635 4.00%
1983 0.9321 0.8610 1.0685 0.8405 0.9264 6.81%
1982 0.7880 0.8764 0.8994 0.6585 0.8673 -0.16%
1981 0.8909 0.8815 1.0494 0.7841 0.8687 0.00%
1980 0.7456 0.7252 0.8687 0.6022 0.8687 17.31%
1979 0.6921 0.6958 0.7571 0.6418 0.7405 6.84%
1978 0.5903 0.5496 0.7086 0.4933 0.6931 21.83%
1977 0.5756 0.6867 0.6867 0.5164 0.5689 -18.52%
1976 0.7330 0.7137 0.8239 0.6457 0.6982 -1.63%
1975 0.7633 0.6893 0.8764 0.6022 0.7098 4.32%
1974 0.7366 0.8239 0.8776 0.5022 0.6804 -17.80%
1973 0.9156 0.9276 1.0301 0.7969 0.8277 -9.39%
1972 0.7829 0.6419 0.9173 0.6419 0.9135 43.75%
1971 0.5433 0.4869 0.6701 0.4869 0.6355 25.25%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $220.845B $42.294B
Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate the countries to deliver innovative health solutions. The Company also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $371.421B 16.92
Pfizer (PFE) United States $251.806B 14.10
Novartis AG (NVS) Switzerland $214.807B 18.27
Eli Lilly (LLY) United States $131.074B 22.77
Novo Nordisk (NVO) Denmark $127.625B 20.64
AbbVie (ABBV) United States $119.216B 10.22
Sanofi (SNY) France $113.215B 13.98
AstraZeneca (AZN) United Kingdom $108.585B 12.39
GlaxoSmithKline (GSK) United Kingdom $100.340B 13.18
Bristol-Myers Squibb (BMY) United States $80.981B 12.46